ALMS Tambahing bathi saben saham ing taun lumaku Alumis Inc.

ALMS (Alumis Pharma) - tandha merek perusahaan

High barriers to entry and patent protection shield Alumis Inc. (ALMS) from the expansion of new players. This chart on GURU.Markets, showing the annual percentage growth of net income per share, demonstrates resilience, with the latest value recorded as -14.00. The diversification of research into autoimmune pathologies mitigates risks, while the strategy focuses on completing the final clinical phases of targeted drugs.

Wutah bathi saben saham ing taun lumaku: Alumis Inc (ALMS) kanggo 29.06.2024 - 12.11.2026

Rincian metrik keuangan lan pasar Alumis Inc. (ALMS)

- nilai pasar lan prakiraan target analis:
Rega saham Alumis Inc|ALMS - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar Alumis Pharma|ALMS - Nilai Total Perusahaan
- rincian valuasi buku bisnis:
Nilai Aset Bersih saben Saham Alumis|ALMS - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku alumis.com|ALMS - Aset Agregat Perusahaan
- rincian utang lan likuiditas:
Utang marang Modal Alumis Inc.|ALMS - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas alumis.com|ALMS - Gunggung utang perusahaan|Utang-utang marang nilai buku Alumis Pharma|ALMS - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Alumis|Likuiditas cepet alumis.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
ALMS - Penghasilan resik|Proyeksi bathi mangsa ngarep Alumis Inc.|ALMS - Rasio rega marang bathi|Prakiraan rega marang bathi Alumis Pharma|ALMS - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Alumis Pharma|ALMS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan Alumis|ALMS - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan alumis.com|ALMS - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Alumis Inc.
Ringkesan analisis perusahaan:ALMS Alumis Inc
Produk mawa merek Alumis Inc.

The operational efficiency of Alumis Inc. (ALMS) is directly reflected in the rate of change in net earnings per share compared to the same period last year. This indicator measures fundamental growth in profitability, which, for this biotechnology company utilizing a full outsourcing model for production and trials, minimizes the impact of capital expenditures, as clearly demonstrated by this year-over-year EPS trend.

Pesaing langsung

Jazz Pharmaceuticals PLC (JAZZ) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku Cytokinetics Inc|PTCT: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Scholar Rock (SRRK)|CNTA - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Dyne Therapeutics DYN|Edgewise Therapeutics Inc - Wutah bathi saben saham ing taun lumaku|RAPP - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Zevra Corp|CTNM: Wutah bathi ing taun lumaku|Owah-owahan bathi resik saben saham ing taun lumaku larimartx.com LRMR|Wutah bathi resik saben saham ing taun iki CAPR|Kacepetan wutah bathi saben saham ing taun lumaku Entrada Therapeutics Inc. TRDA|Wutah bathi ing taun lumaku PTHS|Wutah bathi ing taun lumaku medicinova.com (MNOV)|Wutah bathi saben saham ing taun lumaku Serina Therapeutics, Inc. SER|bioxceltherapeutics.com - Wutah bathi saben saham ing taun lumaku|PMN: Wutah bathi resik saben saham ing taun iki|APUS - Wutah bathi ing taun lumaku|aeonbiopharma.com (AEON) - Wutah bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki NLS Pharmaceutics|BNOX (Bionomics Ltd.) - Wutah bathi ing taun lumaku|fsdpharma.com (HUGE) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Reata Pharmaceuticals, Inc. (RETA)